Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
98M
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
5.78M
-
Shares change
-
+2.13K
-
Total reported value, excl. options
-
$25.7M
-
Value change
-
+$251K
-
Number of buys
-
12
-
Number of sells
-
-8
-
Price
-
$4.45
Significant Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q1 2021
23 filings reported holding ATYR - aTYR PHARMA INC - COMMON STOCK as of Q1 2021.
aTYR PHARMA INC - COMMON STOCK (ATYR) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.78M shares
of 98M outstanding shares and own 5.9% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (1.62M shares), FMR LLC (1.58M shares), Alyeska Investment Group, L.P. (984K shares), Ikarian Capital, LLC (300K shares), VANGUARD GROUP INC (295K shares), BlackRock Inc. (253K shares), RENAISSANCE TECHNOLOGIES LLC (242K shares), Telemetry Investments, L.L.C. (118K shares), ACADIAN ASSET MANAGEMENT LLC (103K shares), and DIMENSIONAL FUND ADVISORS LP (64.4K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.